Beca Training at Bristol-Myers Squibb

Madrid, Community of Madrid, Spain

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates must be currently pursuing a degree in Business, Life Sciences, Psychology, Education, Communication, or a related field. They should possess a strong interest in learning & development and/or the pharmaceutical industry, along with excellent communication and organizational skills. Proficiency in Microsoft Office Suite (PowerPoint, Excel, Word) is required, as is the ability to be proactive, curious, and eager to learn in a fast-paced environment. The candidate must be able to work collaboratively within a team and be fluent in English, both written and spoken.

Responsibilities

The Training Intern will assist in the design, preparation, and delivery of training materials for new product launches. They will support the development and rollout of commercial training programs, including soft skills and hard skills. Responsibilities also include collaborating with cross-functional teams, participating in the evaluation of training effectiveness, conducting research on best practices, and helping to coordinate workshops and webinars. The intern will also maintain and update training documentation, presentations, and e-learning modules.

Skills

Product Launch

Training Development

Soft Skills Training

Hard Skills Training

Communication

Negotiation

Leadership

Product Knowledge

Sales Techniques

Digital Tools

Cross-functional Collaboration

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free